PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants
Authors:
- Akira AinaiAAAkira Ainai
- Masato TashiroMTMasato Tashiro
- Tetsutaro SataTSTetsutaro Sata
- Hideki HasegawaHHHideki Hasegawa
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Innate sensors of influenza virus: clues to developing better intranasal vaccinesExpert Review of Vaccines, 2008
- Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza VaccineThe Journal of Infectious Diseases, 2007
- Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challengeMicrobes and Infection, 2007
- TLR3 Is Essential for the Induction of Protective Immunity against Punta Toro Virus Infection by the Double-Stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): Differential Recognition of Synthetic dsRNA MoleculesThe Journal of Immunology, 2007
- Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemicExpert Review of Vaccines, 2007
- Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infectionMicrobes and Infection, 2006
- Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality systemVaccine, 2005
- Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus InfectionJournal of Virology, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Protection Against Influenza Virus Infection in Polymeric Ig Receptor Knockout Mice Immunized Intranasally with Adjuvant-Combined VaccinesThe Journal of Immunology, 2002